Search research articles
Contact Us
Filters
Showing results (231-240 of 286) with videos related to
Page
of 29
Sort By:
Biorxiv : the Preprint Server for Biology
|
April 17, 2023
Hepatocyte Dedifferentiation Profiling In Alcohol-Related Liver Disease Identifies CXCR4 As A Driver Of Cell Reprogramming
Beatriz Aguilar-Bravo, Silvia Ariño, Delia Blaya, et al.
The Lancet. Oncology
|
April 8, 2018
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study
Lorenza Rimassa, Eric Assenat, Markus Peck-Radosavljevic, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 30, 2022
Management of alcohol-related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines
Alexandre Louvet, Jean-Baptiste Trabut, Christophe Moreno, et al.
Hepatology (Baltimore, Md.)
|
December 6, 2012
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial
Rafael Bañares, Frederik Nevens, Fin Stolze Larsen, et al.
Hepatology (Baltimore, Md.)
|
December 10, 2017
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Zobair M Younossi, Rohit Loomba, Mary E Rinella, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 2, 2025
An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical Practice
Luis Antonio Diaz, Veeral Ajmera, Juan Pablo Arab, et al.
Journal of Hepatology
|
April 23, 2023
Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming
Beatriz Aguilar-Bravo, Silvia Ariño, Delia Blaya, et al.
The Lancet. Infectious Diseases
|
March 17, 2015
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)
Marc Bourlière, Jean-Pierre Bronowicki, Victor de Ledinghen, et al.
Hepatology (Baltimore, Md.)
|
December 10, 2017
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
Zobair M Younossi, Rohit Loomba, Quentin M Anstee, et al.
The American Journal of Gastroenterology
|
September 2, 2020
Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers
John B Whitfield, Steven Masson, Suthat Liangpunsakul, et al.
Page
of 29
Search research articles
Search
Showing results (231-240 of 286) with videos related to
Sort By:
Page
of 29
Biorxiv : the Preprint Server for Biology
|
April 17, 2023
Hepatocyte Dedifferentiation Profiling In Alcohol-Related Liver Disease Identifies CXCR4 As A Driver Of Cell Reprogramming
Beatriz Aguilar-Bravo, Silvia Ariño, Delia Blaya, et al.
The Lancet. Oncology
|
April 8, 2018
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study
Lorenza Rimassa, Eric Assenat, Markus Peck-Radosavljevic, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 30, 2022
Management of alcohol-related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines
Alexandre Louvet, Jean-Baptiste Trabut, Christophe Moreno, et al.
Hepatology (Baltimore, Md.)
|
December 6, 2012
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial
Rafael Bañares, Frederik Nevens, Fin Stolze Larsen, et al.
Hepatology (Baltimore, Md.)
|
December 10, 2017
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Zobair M Younossi, Rohit Loomba, Mary E Rinella, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 2, 2025
An Expert Consensus Delphi Panel in Metabolic Dysfunction- and Alcohol-associated Liver Disease: Opportunities and Challenges in Clinical Practice
Luis Antonio Diaz, Veeral Ajmera, Juan Pablo Arab, et al.
Journal of Hepatology
|
April 23, 2023
Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming
Beatriz Aguilar-Bravo, Silvia Ariño, Delia Blaya, et al.
The Lancet. Infectious Diseases
|
March 17, 2015
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)
Marc Bourlière, Jean-Pierre Bronowicki, Victor de Ledinghen, et al.
Hepatology (Baltimore, Md.)
|
December 10, 2017
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
Zobair M Younossi, Rohit Loomba, Quentin M Anstee, et al.
The American Journal of Gastroenterology
|
September 2, 2020
Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk Drinkers
John B Whitfield, Steven Masson, Suthat Liangpunsakul, et al.
Page
of 29